Frontiers | Science News

Science News post list

435 news posts in Life sciences

Life sciences

26 Feb 2021

New open-source platform accelerates research into the treatment of heart arrhythmias

By Rozi Harsanyi / School of Biomedical Engineering & Imaging Sciences, King’s College London Image: megaflopp / Shutterstock An open-source platform, OpenEP co-developed by researchers from the School of Biomedical Engineering & Imaging Sciences at King’s College London has been made available to advance research on atrial fibrillation, a condition characterized by an irregular and often fast heartbeat. It can cause significant symptoms such as breathlessness, palpitations and fatigue, as well as being a major contributor to stroke and heart failure. Current research into the condition involves the interpretation of large amounts of clinical patient data using software written by individual research groups. But a new study recently published in Frontiers in Physiology shows that the OpenEP platform, developed in collaboration between King’s College London, the University of Edinburgh, Invicro, a Konica Minolta Company, Guy’s and St Thomas’ NHS Foundation Trust and Imperial College London, is capable of doing close to 90 per cent of the types of analyses that are performed in contemporary electrophysiology studies, enabling researchers to focus on their specific hypothesis or research question. Having a standardized way of using data processing techniques can also help to make them reproducible for other scientists. Lead author, Dr Steven […]

Life sciences

05 Feb 2021

Chief Editor of Organic Chemistry is elected to the European Academy of Sciences

Professor Iwao Ojima We are proud to announce that Professor Iwao Ojima, Chief Editor of the Organic Chemistry section of  Frontiers in Chemistry has been recently elected to the European Academy of Sciences (EurASc) as a Fellow. Iwao Ojima is professor at the Department of Chemistry, College of Arts and Sciences, as well as the director of the Institute of Chemical Biology and Drug Discovery, Stony Brook University. He received his PhD from the University of Tokyo. Throughout his research career, Dr. Ojima has had numerous ties to the European scientific community – he was first recognized by European chemistry communities in organometallic chemistry, catalysis and fluorine chemistry, prior to joining the faculty at Stony Brook. His inventions on natural product-based anticancer agents were licensed to both French and Italian pharmaceutical companies. In addition, he served on the External Advisory Board of a highly innovative and successful multidisciplinary Center of Excellence, “Cell in Motion,” at the University of Münster and the Max Planck Institute for Molecular Biomedicine in Münster, Germany. He received numerous awards and honors, including 4 National Awards from the American Chemical Society in 4 different fields of chemistry, which is a very rare achievement. The European Academy of Sciences (EURASC) – the pan-European […]